Magnetic Resonance (MR) Imaging in the Post Operative Follow-up of Cholesteatoma in Children
NCT ID: NCT00682409
Last Updated: 2014-08-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
37 participants
INTERVENTIONAL
2008-01-31
2011-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparing MRI to CT on Pediatric Craniosynostosis.
NCT04704284
Laryngeal Mask Position in Magnetic Resonance Imaging in Children
NCT02940652
Outcomes and Prognostic Factors of Acute Mastoiditis in the Grand-Est Region
NCT07122440
Thoracic MRI Imaging in Children
NCT02714933
Analysis of Bronchial Remodeling Using Resonance Magnetic Imaging in Severe Asthmatic childrEn
NCT05419622
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Analysis of the value of the imaging of distribution and the late sequence to differentiate the cholesteatoma of the fibrosis in the follow-up operating post at the child
MR Imaging
MR imaging in the post operative follow-up of cholesteatoma in children
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MR Imaging
MR imaging in the post operative follow-up of cholesteatoma in children
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Child having benefited from a surgical operation for cholesteatoma of the average ear acquired or congenital, one-sided or bilateral
* Child for whom an additional operating time is indicated
* Child without contraindication in the MRI
* Child having signed a enlightened assent
* Child among whom the parents or the legal representatives signed a enlightened assent
Exclusion Criteria
* Child presenting a chronic renal insufficiency
* Child for whom an additional operating time is not indicated
* Child having a contraindication in the MRI
* Child not having signed the assent or the parents of which did not sign the assent
5 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique Hopitaux De Marseille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brigitte BOURLIERE NAJEAN, MD
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique des Hôpitaux de Marseille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital de la Timone- Service de radiologie pédiatrique et d'ORL pédiatrique
Marseille, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2007-22
Identifier Type: -
Identifier Source: secondary_id
2007-A00743-50
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.